Pre-Market Review: Isis Pharmaceuticals Inc., Community Health Systems Inc., Quest Diagnostics Inc., and Santarus Inc.
Editor Note: For more information about this release, please scroll to bottom.
12 Sep, 2013, 11:12 ET
LONDON, September 12, 2013 /PRNewswire/ --
On Wednesday September 11, 2013, the U.S. equity market ended on a mixed note. The S&P 500 and the Dow Jones Industrial Average gained 0.31% and 0.89%, respectively, while the NASDAQ Composite fell by 0.11%. Shares in the healthcare sector ended lower, even as the broader market closed on a mixed note. The major movers in the sector included Isis Pharmaceuticals Inc. (NASDAQ: ISIS), Community Health Systems Inc. (NYSE: CYH), Quest Diagnostics Inc. (NYSE: DGX), and Santarus Inc. (NASDAQ: SNTS). AAAResearchReports.com initiated preliminary technical research on ISIS, CYH, DGX, and SNTS. These free reports are accessible by signing today at:
On Wednesday, Isis Pharmaceuticals Inc.'s shares edged lower to end the day at $31.33, which is 0.92% lower than the previous day's closing price of $31.62. The company's shares fluctuated between $30.89 and $31.60 during the trading session. A total of 0.91 million shares were traded, which is below the daily average volume of 1.56 million. Despite Wednesday's losses, Isis Pharmaceuticals Inc.'s shares have gained 12.21% in the previous three trading sessions and 32.47% in the last three months, outperforming the S&P 500 during both the periods. Further, the company's stock is trading above its 50-day and 200-day moving averages of $28.46 and $19.64, respectively. The free technical analysis on ISIS is available by signing up at:
Community Health Systems Inc.'s stock fell by 0.67% on Wednesday, after rising sharply in the previous trading session. The company's shares vacillated between $38.49 and $39.51 before finishing the day at $38.77. A total of 1.63 million shares were traded, which is below the daily average volume of 1.67 million. Community Health Systems Inc.'s shares have declined by 2.29% during the previous three trading sessions, underperforming the S&P 500 which has advanced 2.05% during the same period. Furthermore, the company's stock is trading below its 50-day and 200-day moving averages of $43.64 and $41.36, respectively. Register now to download free research on CYH at:
Shares in Quest Diagnostics Inc. rose marginally on Wednesday, extending their gains from previous trading sessions. The company's shares closed the day at $61.79, up 0.05% from the previous day's price of $61.76. The company's shares fluctuated between $61.32 and $61.91 during the trading session. A total of 1.03 million shares were traded, which is below the daily average volume of 1.24 million. The company's shares have gained 4.06% in the last one month, compared to a loss of 0.14% in the S&P 500 during the same period. Moreover, Quest Diagnostics Inc.'s stock is trading above its 50-day and 200-day moving averages of $59.28 and $58.73, respectively. A free report on DGX can be accessed by registering at:
Santarus Inc.'s shares plummeted on Wednesday, extending their losses from previous trading sessions. The company's shares ended the day 2.87% lower at $21.65 after fluctuating between $21.45 and $22.25. A total of 1.74 million shares were traded, which is above the daily average volume of 1.55 million. Despite the recent losses, the company's stock is trading above its 200-day moving average of $17.98. Additionally, Santarus Inc.'s shares have fallen by 1.28% in the previous three months, compared to a gain of 3.87% in the S&P 500 during the same period. Register with AAA Research Reports and download research on SNTS for free at:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by an analyst. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected].
- For any urgent concerns or inquiries, please contact us at [email protected].
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to [email protected] for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
SOURCE AAA Research Reports
Share this article